FDA Warns Of Diabetes Drugs From AstraZeneca, Janssen
The U.S. Food and Drug Administration on Friday warned of serious blood problems linked to use of six diabetes drugs, including AstraZeneca PLC's Farxiga and Janssen Pharmaceuticals Inc.'s Invokana....To view the full article, register now.
Already a subscriber? Click here to view full article